Sciencast Management LP Acquires New Position in Option Care Health, Inc. (NASDAQ:OPCH)

Sciencast Management LP bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 36,867 shares of the company's stock, valued at approximately $855,000.

A number of other hedge funds also recently made changes to their positions in the business. FMR LLC grew its holdings in Option Care Health by 134.0% during the third quarter. FMR LLC now owns 7,516,448 shares of the company's stock valued at $235,265,000 after purchasing an additional 4,304,896 shares during the period. Wellington Management Group LLP grew its stake in shares of Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after acquiring an additional 1,328,326 shares during the period. Westfield Capital Management Co. LP grew its stake in shares of Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after acquiring an additional 599,589 shares during the period. Victory Capital Management Inc. increased its holdings in Option Care Health by 31.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after acquiring an additional 503,840 shares during the last quarter. Finally, Magnetar Financial LLC raised its stake in Option Care Health by 23.1% in the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock valued at $54,534,000 after acquiring an additional 441,265 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. JMP Securities reiterated a "market outperform" rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective for the company. JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and an average price target of $33.00.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $0.17 during trading on Thursday, hitting $35.20. The stock had a trading volume of 1,224,299 shares, compared to its average volume of 1,643,535. The firm has a market cap of $5.78 billion, a price-to-earnings ratio of 29.58, a P/E/G ratio of 2.30 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The business's 50-day moving average is $32.24 and its 200 day moving average is $28.37. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.